for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Owens & Minor, Inc.

OMI

Latest Trade

14.25USD

Change

-2.37(-14.26%)

Volume

4,608,063

Today's Range

13.71

 - 

16.90

52 Week Range

2.75

 - 

17.33

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
16.62
Open
16.72
Volume
4,608,063
3M AVG Volume
61.47
Today's High
16.90
Today's Low
13.71
52 Week High
17.33
52 Week Low
2.75
Shares Out (MIL)
63.01
Market Cap (MIL)
1,047.19
Forward P/E
15.62
Dividend (Yield %)
0.06

Next Event

Dividend For OMI.N - 0.0025 USD

Latest Developments

More

Owens & Minor Reports 2nd Quarter Financial Results

Owens & Minor Sees Q2 2020 Adjusted Non-GAAP EPS $0.18 To $0.20

Owens & Minor Files For Mixed Shelf Of Upto $300 Million

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Owens & Minor, Inc.

Owens & Minor, Inc. is a healthcare solutions company with integrated technologies, products and services. The Company operates through two segments: Global Solutions and Global Products. Global Solutions segment includes its United States distribution, outsourced logistics and value-added services business. Global Products manufactures and sources medical surgical products through its production and kitting operations. Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes products purchased from manufacturers and its own proprietary products. Global Products segment provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its manufacturing facilities are located in the United States, Thailand, Honduras, Mexico and Ireland.

Industry

Medical Equipment & Supplies

Contact Info

9120 LOCKWOOD BLVD

MECHANICSVILLE, VA

23116

United States

+1.804.7237000

http://www.owens-minor.com/

Executive Leadership

Robert C. Sledd

Independent Chairman of the Board

Edward A. Pesicka

President, Chief Executive Officer, Director

Andrew G. Long

Chief Financial Officer, Executive Vice President

Christopher M. Lowery

President - Global Products

Jeffrey T. Jochims

Chief Operating Officer, Executive Vice President

Key Stats

2.86 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

9.3K

2018

9.8K

2019

9.2K

2020(E)

8.5K
EPS (USD)

2017

1.610

2018

1.150

2019

0.600

2020(E)

1.061
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.12
Price To Book (MRQ)
2.51
Price To Cash Flow (TTM)
11.73
Total Debt To Equity (MRQ)
356.52
LT Debt To Equity (MRQ)
356.52
Return on Investment (TTM)
-0.97
Return on Equity (TTM)
-0.59

Latest News

Latest News

BRIEF-Owens & Minor Announces Cash Tender Offers For Senior Notes

* OWENS & MINOR ANNOUNCES CASH TENDER OFFERS FOR SENIOR NOTES

BRIEF-Owens & Minor Says Entered Equity Distribution Agreement With Citigroup Global Markets

* OWENS & MINOR - ENTERED EQUITY DISTRIBUTION AGREEMENT WITH CITIGROUP GLOBAL MARKETS

BRIEF-Owens & Minor Files For Mixed Shelf Of Upto $300 Million

* OWENS & MINOR INC FILES FOR MIXED SHELF OF UPTO $300 MILLION - SEC FILING Source text for Eikon: (https://bit.ly/2WfHxUG) Further company coverage:

BRIEF-Owens & Minor Reports Q1 Adjusted Earnings Per Share $0.08

* Q1 EARNINGS PER SHARE ESTIMATE $0.04 -- REFINITIV IBES DATA

BRIEF-Owens & Minor Says Entered Agreement For Sale Of Movianto Business, Certain Support Functions In Dublin Office, To Walden Group Sas

* OWENS & MINOR INC - ON APRIL 6, ENTERED AGREEMENT FOR SALE OF MOVIANTO BUSINESS, CERTAIN SUPPORT FUNCTIONS IN DUBLIN OFFICE, TO WALDEN GROUP SAS

BRIEF-Owens & Minor Posts Qtrly Loss Per Share Of $0.65

* OWENS & MINOR REPORTS 4TH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday:

Exclusive: Healthcare logistics company Owens & Minor explores sale - sources

Owens & Minor Inc is exploring a sale of the company, people familiar with the matter said on Wednesday, as the U.S. medical supplies distributor seeks to recover from a string of disappointing earnings.

BRIEF-Owens & Minor Sets Quarterly Dividend Of $0.26 Per Share

* SETS QUARTERLY DIVIDEND OF $0.26PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Owens & Minor Reports Q1 Adjusted Non-GAAP Earnings Per Share Of $0.43

* Q1 EARNINGS PER SHARE VIEW $0.47 -- THOMSON REUTERS I/B/E/S

BRIEF-Owens & Minor CEO P. Cody Phipps' Total Pay For 2017 Was $6.7 Mln Vs $6.3 Mln In 2016 - SEC Filing

* OWENS & MINOR CEO P. CODY PHIPPS' TOTAL COMPENSATION FOR 2017 WAS $6.7 MILLION VERSUS $6.3 MILLION IN 2016 - SEC FILING Source text: (https://bit.ly/2DXIvZj) Further company coverage:

BRIEF-Owens & Minor Names Dominion Energy Executive To Its Board

* OWENS & MINOR NAMES DOMINION ENERGY EXECUTIVE, MARK MCGETTRICK, TO ITS BOARD OF DIRECTORS

BRIEF-Owens & Minor Q4 Revenue $2.39 Bln Versus $2.37 Bln

* OWENS & MINOR REPORTS 4TH QUARTER & FULL-YEAR 2017 FINANCIAL RESULTS

BRIEF-Owens & Minor Sees FY'17 EPS Of $1.17 To $1.20

* OWENS & MINOR REVISES EXPECTATIONS FOR 2017 EARNINGS AND REVENUES

BRIEF-Owens & Minor Announces Updates On Pending Acquisition Of Halyard Health's S&IP Business

* OWENS & MINOR ANNOUNCES UPDATES ON PENDING ACQUISITION OF HALYARD HEALTH’S S&IP BUSINESS

Fitch Downgrades Owens & Minor, Inc.'s IDR to 'BB+'; Outlook to Negative

(The following statement was released by the rating agency) NEW YORK, November 03 (Fitch) Fitch Ratings has downgraded the Long-Term Issuer Default Rating (IDR) of Owen & Minor, Inc. to 'BB+' from 'BBB-'. The Rating Outlook is revised to Negative from Stable. A full list...

BRIEF-Halyard Health to sell S&IP business to Owens & Minor

* Halyard Health, Inc. announces sale of S&IP business to Owens & Minor, Inc. for $710 million

BRIEF-Owens & Minor to buy Halyard Health's surgical & infection prevention business for $710 mln

* Owens & Minor to acquire Halyard Health Inc's surgical & infection prevention (S&IP) business for $710 million in cash

BRIEF-Owens & Minor Q3 adjusted earnings per share $0.40

* Q3 earnings per share view $0.50 -- Thomson Reuters I/B/E/S

BRIEF-Owens & Minor Q2 earnings per share $0.33

* Q2 earnings per share view $0.43 -- Thomson Reuters I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up